Top Stories: Page 11

DEA’s Likely Administrator Refuses to Commit to Schedule III Proposal for Cannabis

Terry Cole said at his nomination hearing that he’ll move the hearing process forward, but he needs to know more about the science behind the proposal.

2 US House Reps Introduce Bill to Allow White House Drug Adviser to Publicly Back Cannabis Legalization

Congresswomen Dina Titus and Ilhan Omar’s legislative proposal would also allow the White House to sponsor and fund cannabis research.

Oklahoma Governor Calls for Statewide Crackdown on ‘Psychoactive Marijuana Byproducts’

Gov. Kevin Stitt sent a letter to multiple state agencies, tasking them with coordinating an enforcement plan against unregulated products.

How to Manage an Inherited Powdery Mildew Outbreak

A CBT reader asks industry expert Ken Morrow how to manage a PM issue at a cannabis facility in a tropical climate.

Innovating for the Benefit of Patients in Medical Cannabis (Opinion)

Poor bioavailability formulations in orally delivered medical cannabis have left an innovation gap for patients.

Federal Judge Rules Medical Cannabis Isn’t Covered by Insurance

The U.S. district judge determined New Mexico law doesn’t mandate coverage, and, if it did, such a law would be preempted by federal law.

Delaware’s Adult-Use Sales Launch Back On; Governor Signs FBI Fix

Gov. Matt Meyer said legislation to run background checks on industry participants will help establish ‘good-paying’ jobs for Delawareans.

California Lawmakers Vote, 15-0, To Repeal Cannabis Excise Tax Increase

The California Assembly Business and Professions Committee unanimously advanced legislation to prevent a 27% rate increase scheduled for July 1.

Delaware’s FBI Mix-Up, Minnesota’s Lottery, DEA’s Inaction Lead CBT’s Top Stories in April

Delaware and Minnesota’s adult-use delays and the DEA's dragging its feet were the most-read articles in Cannabis Business Times this month.

Judge Sends Alabama Medical Cannabis Licensing Back to Square One

Circuit Judge James Anderson ruled that the state regulators’ emergency rule, established for a late 2023 licensing process, is void.

Doctors Group Left Out of DEA’s Cannabis Rescheduling Hearing Drops Lawsuit

Doctors for Drug Policy Reform preserves the right to refile the case should the Drug Enforcement Administration opt to keep cannabis a Schedule I drug.

US House Reps File Bill to Legalize Cannabis, Deliver 280E Relief, Permit Interstate Commerce

Three bipartisan U.S. lawmakers reintroduced the STATES Act to federally deschedule cannabis and end 85-plus years of prohibition.

Previous Page

Page 11 of 257

Next Page